Australia markets closed

Wai Chun Bio-Technology Limited (0660.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.100+0.015 (+17.65%)
At close: 03:57PM HKT

Wai Chun Bio-Technology Limited

China Resources Building
Rooms 4001-02, 40th Floor 26 Harbour Road
Wanchai
Hong Kong
852 3102 9989
https://www.0660.hk

Sector(s)Basic Materials
IndustryChemicals
Full-time employees130

Key executives

NameTitlePayExercisedYear born
Mr. Ka Chun LamMD, CEO & Executive Chairman727kN/A1992
Mr. Shen Chuan FengFounder602kN/A1944
Mr. Kai Kei LamCompany SecretaryN/AN/A1986
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Wai Chun Bio-Technology Limited, an investment holding company, engages in the manufacturing and selling of modified starch and other biochemical products in the People's Republic of China. The company was formerly known as Wai Chun Mining Industry Group Company Limited and changed its name to Wai Chun Bio-Technology Limited in September 2019. Wai Chun Bio-Technology Limited was incorporated in 1992 and is headquartered in Wanchai, Hong Kong.

Corporate governance

Wai Chun Bio-Technology Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.